BIOMAT Database Logo BIOMAT Database Logo

Investigation of nosocomial infection caused by arbekacin-resistant, methicillin-resistant Staphylococcus aureus. 1997

Y Obayashi, and J Fujita, and S Ichiyama, and S Hojo, and K Negayama, and C Takashima, and H Miyawaki, and T Tanabe, and Y Yamaji, and K Kawanishi, and J Takahara
First Department of Internal Medicine, Kagawa Medical University, Japan.

An outbreak of coagulase VII-producing, arbekacin (ABK)-resistant, methicillin-resistant Staphylococcus aureus (MRSA) occurred between September 1994 and December 1995, involving five different wards. Twenty-one patients developed skin, wound, drainage, or respiratory tract colonization with coagulase VII-producing, (ABK)-resistant MRSA. Phenotypic characteristics (production of enterotoxin and TSST-1, antimicrobial susceptibility) and molecular-typing procedure (plasmid DNA profile, pulsed-field gel electrophoresis [PFGE] and arbitrarily primed polymerase chain reaction [AP-PCR] of chromosomal DNA) in isolated strains were compared. Plasmid analysis identified four different profiles and 19 of 22 strains recovered had identical patterns. PFGE of chromosomal DNA identified three different subtypes and 18 (81.8%) isolates shared the same subtype. AP-PCR also demonstrated that most strains had the same phenotypic characteristics. Although traditional epidemiological methods; for example, coagulase typing, plays a central role in hospital infection control, combination of plasmid DNA profile, AP-PCR, and PFGE may prove to be a particularly informative means of tracking the nosocomial spread of MRSA.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D003428 Cross Infection Any infection which a patient contracts in a health-care institution. Hospital Infections,Nosocomial Infections,Health Care Associated Infection,Health Care Associated Infections,Healthcare Associated Infections,Infection, Cross,Infections, Hospital,Infections, Nosocomial,Cross Infections,Healthcare Associated Infection,Hospital Infection,Infection, Healthcare Associated,Infection, Hospital,Infection, Nosocomial,Infections, Cross,Infections, Healthcare Associated,Nosocomial Infection
D003982 Dibekacin Analog of KANAMYCIN with antitubercular as well as broad-spectrum antimicrobial properties. Dideoxykanamycin B,3',4'-Dideoxykanamycin B,Dibekacin Sulfate,Dibekacin Sulphate,Dideoxykanamycine,Orbicin,3',4' Dideoxykanamycin B,B, 3',4'-Dideoxykanamycin,Sulfate, Dibekacin,Sulphate, Dibekacin
D004196 Disease Outbreaks Sudden increase in the incidence of a disease. The concept includes EPIDEMICS and PANDEMICS. Outbreaks,Infectious Disease Outbreaks,Disease Outbreak,Disease Outbreak, Infectious,Disease Outbreaks, Infectious,Infectious Disease Outbreak,Outbreak, Disease,Outbreak, Infectious Disease,Outbreaks, Disease,Outbreaks, Infectious Disease
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000369 Aged, 80 and over Persons 80 years of age and older. Oldest Old

Related Publications

Y Obayashi, and J Fujita, and S Ichiyama, and S Hojo, and K Negayama, and C Takashima, and H Miyawaki, and T Tanabe, and Y Yamaji, and K Kawanishi, and J Takahara
Nosocomial infection caused by methicillin-resistant Staphylococcus aureus in Palestine.
January 2005, Microbial drug resistance (Larchmont, N.Y.),
Y Obayashi, and J Fujita, and S Ichiyama, and S Hojo, and K Negayama, and C Takashima, and H Miyawaki, and T Tanabe, and Y Yamaji, and K Kawanishi, and J Takahara
[Nosocomial bacteremia++ caused by methicillin-resistant Staphylococcus aureus].
November 1992, Enfermedades infecciosas y microbiologia clinica,
Y Obayashi, and J Fujita, and S Ichiyama, and S Hojo, and K Negayama, and C Takashima, and H Miyawaki, and T Tanabe, and Y Yamaji, and K Kawanishi, and J Takahara
[Nosocomial infection with methicillin-resistant Staphylococcus aureus].
September 1990, Rinsho byori. The Japanese journal of clinical pathology,
Y Obayashi, and J Fujita, and S Ichiyama, and S Hojo, and K Negayama, and C Takashima, and H Miyawaki, and T Tanabe, and Y Yamaji, and K Kawanishi, and J Takahara
Epidemiology of nosocomial infections caused by methicillin-resistant Staphylococcus aureus.
September 1982, Annals of internal medicine,
Y Obayashi, and J Fujita, and S Ichiyama, and S Hojo, and K Negayama, and C Takashima, and H Miyawaki, and T Tanabe, and Y Yamaji, and K Kawanishi, and J Takahara
Control of nosocomial methicillin-resistant Staphylococcus aureus infection.
August 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
Y Obayashi, and J Fujita, and S Ichiyama, and S Hojo, and K Negayama, and C Takashima, and H Miyawaki, and T Tanabe, and Y Yamaji, and K Kawanishi, and J Takahara
[Risk factors of nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus].
February 2012, Medicina clinica,
Y Obayashi, and J Fujita, and S Ichiyama, and S Hojo, and K Negayama, and C Takashima, and H Miyawaki, and T Tanabe, and Y Yamaji, and K Kawanishi, and J Takahara
[Nosocomial infections caused by Staphylococcus aureus resistant to methicillin. A challenge for infection control].
April 1991, Enfermedades infecciosas y microbiologia clinica,
Y Obayashi, and J Fujita, and S Ichiyama, and S Hojo, and K Negayama, and C Takashima, and H Miyawaki, and T Tanabe, and Y Yamaji, and K Kawanishi, and J Takahara
[Emergence of arbekacin resistant strains among methicillin-resistant Staphylococcus aureus].
June 1994, The Japanese journal of antibiotics,
Y Obayashi, and J Fujita, and S Ichiyama, and S Hojo, and K Negayama, and C Takashima, and H Miyawaki, and T Tanabe, and Y Yamaji, and K Kawanishi, and J Takahara
[Antimicrobial activities of arbekacin against methicillin-resistant Staphylococcus aureus].
January 1997, The Japanese journal of antibiotics,
Y Obayashi, and J Fujita, and S Ichiyama, and S Hojo, and K Negayama, and C Takashima, and H Miyawaki, and T Tanabe, and Y Yamaji, and K Kawanishi, and J Takahara
Methicillin-resistant Staphylococcus aureus nosocomial pneumonia.
July 2012, Chest,
Copied contents to your clipboard!